Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
4 studies found for:    ALVINA
Show Display Options
Rank Status Study
1 Completed Nutrition and Physical Activity in Patients With Cerebrovascular Disease
Condition: Cerebrovascular Disorders
Interventions: Dietary Supplement: Conventional diet +/- wine;   Dietary Supplement: Luxembourg variant of Mediterranean diet + physical activity +/- wine
2 Recruiting Evaluation of Skin Quality Improvement
Condition: Skin Quality
Interventions: Drug: Hyper-Diluted Botox;   Drug: Topical anesthesia;   Other: 0.9% saline solution
3 Completed
Has Results
A Multicenter Phase 2 Study of Ibrutinib in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) With 17p Deletion
Conditions: Chronic Lymphocytic Leukemia With 17p Deletion;   Small Lymphocytic Lymphoma With 17p Deletion
Intervention: Drug: Ibrutinib
4 Enrolling by invitation Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia
Conditions: B-cell Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma;   Diffuse Well-differentiated Lymphocytic Lymphoma;   B Cell Lymphoma;   Follicular Lymphoma;   Mantle Cell Lymphoma;   Non-Hodgkin's Lymphoma;   Waldenstrom Macroglobulinemia;   Burkitt Lymphoma;   B-Cell Diffuse Lymphoma
Intervention: Drug: PCI-32765

Study has passed its completion date and status has not been verified in more than two years.